Affiliation:
1. From the Division of Dermatology, University of Calgary, Calgary, AB
Abstract
Background: We report two cases of mosaic generalized neurofibromatosis 1 (NF1) and review the history of the classification of segmental neurofibromatosis (SNF; Ricardi type NF-V). Somatic mutations giving rise to limited disease, such as segmental neurofibromatosis are manifestations of mosaicism. If the mutation occurs before tissue differentiation, the clinical phenotype will be generalized disease. Mutations that occur later in development give rise to disease that is confined to a single region. Objectives: Segmental neurofibromatosis is caused by a somatic mutation of neurofibromatosis type 1, and should not be regarded as a distinct entity from neurofibromatosis 1. Cases previously referred to as unilateral or bilateral segmental neurofibromatosis are now best referred to as mosaic generalized or mosaic localized neurofibromatosis 1.
Reference21 articles.
1. The clinical and diagnostic implications mosaicism in the neurofibromatoses
2. CLEVELAND DERMATOLOGICAL SOCIETY
3. Crowe F, Schull W, Neel J. A clinical, pathological, and genetic study of multiple neurofibromatosis. Springfield, IL: Charles C Thomas Publishers; 1956. p. 1–181.
4. Pathophysiology of Neurofibromatosis Type 1
5. Segmental Neurofibromatosis
Cited by
6 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献